Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 12/20 | 0.62 |
| ▸ | TLR4 | O00206 | 2/20 | 0.58 |
| ▸ | TLR2 | O60603 | 2/20 | 0.58 |
| ▸ | EGFR | P00533 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17070027 | 0.88 | FBP1 (0.64) | FBP1TLR4TLR2EGFRALDH1A1 | |
| SCHEMBL509743 | 0.85 | TLR4 (0.71) | FBP1TLR4TLR2EGFRALDH1A1 | |
| SCHEMBL509742 | 0.85 | TLR4 (0.71) | FBP1TLR4TLR2EGFRALDH1A1 | |
| SCHEMBL1524485 | 0.85 | FBP1 (0.60) | FBP1TLR4TLR2EGFRALDH1A1 | |
| SCHEMBL1524482 | 0.85 | FBP1 (0.60) | FBP1TLR4TLR2EGFRALDH1A1 | |
| SCHEMBL3829457 | 0.83 | FBP1 (0.62) | FBP1TLR4TLR2EGFRALDH1A1 | |
| SCHEMBL16632344 | 0.83 | PTGS2 (0.69) | FBP1TLR4TLR2EGFRALDH1A1 | |
| SCHEMBL16632342 | 0.83 | PTGS2 (0.69) | FBP1TLR4TLR2EGFRALDH1A1 | |
| SCHEMBL17070028 | 0.81 | FBP1 (0.60) | FBP1TLR4TLR2EGFRALDH1A1 | |
| SCHEMBL5688276 | 0.81 | TLR4 (0.66) | FBP1TLR4TLR2EGFRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9518009-B2 | Multifunctional nitrileoxide compound | DAIKIN INDUSTRIES, LTD. (JP) | 2016-12-13 | — | — | US | disclosed |
| US-9518009-B2 | Multifunctional nitrileoxide compound | DAIKIN INDUSTRIES, LTD. (JP) | 2016-12-13 | — | — | US | disclosed |
| US-20150251995-A1 | MULTIFUNCTIONAL NITRILEOXIDE COMPOUND | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2015-09-10 | — | — | US | disclosed |
| US-20150251995-A1 | MULTIFUNCTIONAL NITRILEOXIDE COMPOUND | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2015-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150251995-A1 | MULTIFUNCTIONAL NITRILEOXIDE COMPOUND | NOS2, NOS1, NOS3 | FBP1 4257/4885TLR4 3763/4885TLR2 3655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.